The predictive role of ultrasound remission for progressive structural damage in rheumatoid arthritis patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021850

Enrollment

Unknown

Registered

2019-03-13

Start date

2019-03-11

Completion date

Unknown

Last updated

2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

newly diagnosed rheumatoid arthritis patients:Utrasound examination

established rheumatoid arthritis patients:Utrasound examination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The main inclusion criteria were age > 18 years, fulfilment of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis, indication for conventional or biological disease modifying anti-rheumatic drugs.

Exclusion criteria

Exclusion criteria: Exclusion criteria were pregnancy/pregnancy wish during the study, deformity, injury and surgery of examined joints, loss to follow-up.

Design outcomes

Primary

Measure	Time frame
progression of structural damage;	—

Countries

China

Contacts

Public ContactJiaan Zhu

Peking University People's Hospital

zhujiaan@pkuph.edu.cn+86 010-88325379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026